-
2 weeks ago | 
drugtargetreview.com | Carrie Haslam
Posted: 9 June 2025 | Drug Target Review | A new study suggests statins, cheap and widely used cholesterol drugs, could be repurposed to reduce the risk of death from sepsis. Researchers reported a 39 percent drop in 28-day mortality, highlighting their potential role in critical care. A major new study has found that statins could significantly reduce the risk of death in patients with severe sepsis.
-
3 weeks ago | 
drugtargetreview.com | Carrie Haslam
Posted: 5 June 2025 | Drug Target Review | A rare genetic glitch causes dopamine to leak in the brain – now researchers may have found a way to stop it, without the risks of current treatments. A new study led by scientists at Florida Atlantic University (FAU) offers a promising step forward in the treatment of dopamine-related neuropsychiatric disorders. Unlike current therapies, it avoids the high risk of side effects and addiction.
-
3 weeks ago | 
drugtargetreview.com | Carrie Haslam
Posted: 2 June 2025 | Drug Target Review | Researchers at the University of Illinois have achieved the first successful metabolic labelling of platelets, a key step toward using them in targeted drug delivery. The technique could enable short-lived, precision therapies for cancer, immune conditions, and clotting disorders.
-
4 weeks ago | 
drugtargetreview.com | Carrie Haslam
articlePosted: 30 May 2025 | Carrie Haslam | Forget the buzzwords – SLAS 2025 showed what’s genuinely driving progress in drug discovery: usable AI, collaborative platforms and tools that solve real problems. Drug Target Review had the pleasure of attending SLAS Europe 2025 in Hamburg and what we saw was no mere showcase of cutting-edge tools, but a clear snapshot of where drug discovery is heading.
-
Mar 20, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 20 March 2025 | Drug Target Review | Scientists have developed CeSPIACE, a peptide drug that offers broad protection against COVID-19 variants, including Omicron XBB.1.5. Find out how it targets a stable part of the virus’s spike protein, making it resistant to mutations.
-
Mar 14, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 14 March 2025 | Drug Target Review | Insilico Medicine’s AI-designed drug for idiopathic pulmonary fibrosis (IPF), Rentosertib, has been granted an official name by USAN. This is the first drug where both the target and compound were discovered using generative AI, marking a major milestone in AI-driven drug development.
-
Mar 13, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 13 March 2025 | Drug Target Review | A commonly prescribed diabetes medication could significantly enhance long-term recovery prospects for cancer patients by reducing their risk of heart failure, a new study from the University of East Anglia (UEA) reveals. Protecting the heart during cancer treatmentCancer treatments, particularly chemotherapy, often lead to severe cardiovascular complications that substantially impact patient health and quality of life.
-
Mar 12, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 12 March 2025 | Drug Target Review | Researchers have discovered a breakthrough method to silence MRSA’s drug resistance, restoring its sensitivity to standard antibiotics and offering new hope in the fight against superbugs. A study from the Nanjing University School of Life Sciences has revealed a promising new strategy for combating antibiotic-resistant bacterial infections.
-
Mar 10, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 10 March 2025 | Drug Target Review | Cornell researchers have discovered how transposons, or ‘jumping genes,’ insert themselves into bacterial chromosome ends, potentially transforming genetic engineering and advancing biotechnology. This breakthrough could reshape antibiotic research and unlock new drug discoveries.
-
Mar 7, 2025 | 
drugtargetreview.com | Carrie Haslam
Posted: 7 March 2025 | Drug Target Review | Google has introduced an AI-powered ‘co-scientist’ designed to accelerate biomedical research and drug discovery by generating scientific hypotheses and identifying novel therapeutic targets. Google’s newly introduced AI co-scientist, powered by Gemini 2.0, is designed to assist researchers by generating hypotheses, designing experiments, and analysing complex datasets.
